Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
PSTV
PSTV
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PSTV News
Plus Therapeutics Presents REYOBIQ Clinical Data at AANS Annual Meeting
3d ago
Newsfilter
Plus Therapeutics Secures Medicare Enrollment for CNSide Diagnostics
4d ago
Newsfilter
CNSide Diagnostics Secures Coverage Agreement with Blue Shield of California
Apr 28 2026
Newsfilter
Plus Therapeutics Initiates Manufacturing Activities with SpectronRx
Apr 23 2026
Newsfilter
Plus Therapeutics Appoints New Chief Development Officer
Apr 22 2026
Newsfilter
Plus Therapeutics Stock Meets Nasdaq Minimum Bid Requirement
Apr 21 2026
seekingalpha
Plus Therapeutics Regains Nasdaq Compliance with Minimum Bid Price
Apr 21 2026
Newsfilter
Plus Therapeutics Appoints New VP of Value Strategy
Apr 15 2026
Newsfilter
Plus Appoints New Chief Development Officer and Receives FDA Approval
Apr 10 2026
stocktwits
Plus Therapeutics Appoints New Chief Development Officer
Apr 09 2026
Newsfilter
Plus Therapeutics Receives FDA Orphan Drug Designation
Apr 08 2026
Newsfilter
Plus Therapeutics Secures New CPT Code for CNSide Test
Apr 07 2026
Newsfilter
Plus Therapeutics Secures New Payer Agreement with Highmark
Apr 02 2026
Newsfilter
Plus Therapeutics Grants Inducement Awards to New Employees
Mar 31 2026
Newsfilter
Plus Therapeutics Announces 1-for-25 Reverse Stock Split
Mar 31 2026
seekingalpha
Plus Therapeutics Approves 1-for-25 Reverse Stock Split
Mar 31 2026
Newsfilter
Show More News